Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S. Food ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...
Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC News reported.
During the year ending last August, according to preliminary estimates from the Centers for Disease Control and Prevention ...
With prescription drug costs soaring, Illinois lawmakers announced legislation this week reviving efforts to create a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback